Orthofix Medical Inc.

NASDAQ: OFIX · Real-Time Price · USD
14.32
0.30 (2.14%)
At close: Aug 15, 2025, 2:03 PM

Orthofix Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
809.03M 804.53M 799.49M 784.25M 771.65M 760.04M 746.64M 668.46M 598.45M 529.5M 460.71M 463.55M 461.98M 465.3M 464.48M 457.03M 455.59M 407.33M
Cost of Revenue
255.44M 260.04M 253.61M 263.39M 266.08M 265.36M 264.64M 229.64M 195.97M 160.1M 123.54M 123.75M 121.48M 117.32M 114.91M 110.73M 108.67M 104.39M
Gross Profit
553.59M 544.49M 545.88M 520.86M 505.57M 494.69M 482M 438.82M 402.48M 369.4M 337.17M 339.8M 340.5M 347.99M 349.56M 346.3M 346.92M 302.94M
Operating Income
-95.25M -100.98M -80.28M -87.67M -93.22M -108.11M -135.53M -125.43M -106.36M -76.99M -29.99M -30.57M -25.51M -13.98M -8.31M 4.74M 9.23M -16.04M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-122.7M -140.84M -123.88M -116.21M -117.96M -123.52M -148.68M -133.62M -114.6M -73.64M -17.71M -20.32M -13.49M -11.86M -13.49M 1.68M 9.48M -12.02M
Net Income
-123.71M -143.07M -126M -119.03M -120.49M -126.48M -151.4M -136.28M -118.14M -76.23M -19.75M -45.5M -36.95M -37.02M -38.38M -14.95M -8.12M -28.96M
Selling & General & Admin
536.09M 533.72M 532.42M 528.23M 520.18M 519.48M 530.39M 482.9M 435.61M 377.91M 308.78M 299.34M 296.97M 296.91M 290.67M 287.52M 284.58M 267.43M
Research & Development
71.8M 73.92M 73.64M 73.78M 75.04M 76.42M 80.23M 74.44M 67.83M 61.16M 49.06M 49.16M 49.57M 49.94M 49.62M 46.74M 44.34M 39.99M
Other Expenses
35.45M 32.34M 13.32M 6.01M -508K -528K 1.42M 656K 2.73M 4.8M 6.12M 6.31M 2.45M 1.35M -3.34M -3.53M -1.74M -2.69M
Operating Expenses
643.35M 639.98M 620.67M 608.53M 595.22M 600.53M 615.26M 561.98M 510.13M 443.19M 363.96M 354.62M 352.56M 352.78M 346.19M 340.17M 332.86M 309.39M
Interest Expense
28.59M 29.58M 29.63M 19.21M 15.58M 11.9M 8.63M 4.36M 3.06M 2.2M 1.29M 1.5M 1.65M 1.79M 1.84M 1.83M 2.13M 2.48M
Selling & Marketing Expenses
-200.27M -100.04M n/a 394.59M 392.96M 391.99M 385.74M 347.31M 307.82M 268.46M 228.81M 226.58M 227.22M 224.67M 221.32M 217.94M 214.76M 200.91M
Cost & Expenses
904.28M 905.51M 879.77M 871.92M 861.3M 865.89M 879.9M 791.62M 706.1M 603.29M 487.51M 478.37M 474.04M 470.1M 461.11M 450.9M 441.53M 413.79M
Income Tax Expense
1.01M 2.23M 2.12M 2.81M 2.53M 2.96M 2.72M 2.67M 3.54M 2.58M 2.04M 25.18M 23.47M 25.16M 24.88M 16.63M 17.6M 16.94M
Shares Outstanding (Basic)
39.5M 39.19M 38.7M 38.49M 38.02M 37.74M 37.3M 37.25M 36.76M 35.73M 20.2M 20.09M 20.03M 19.9M 19.81M 19.77M 19.65M 19.39M
Shares Outstanding (Diluted)
39.5M 39.19M 38.7M 38.49M 38.02M 37.74M 37.3M 37.25M 36.76M 35.73M 20.2M 20.09M 20.11M 19.9M 19.86M 19.77M 19.94M 19.53M
EPS (Basic)
-3.17 -3.69 -3.29 -3.13 -3.19 -3.38 -4.14 -3.9 -3.66 -2.47 -0.98 -2.29 -1.87 -1.87 -1.95 -0.78 -0.43 -1.51
EPS (Diluted)
-3.17 -3.69 -3.29 -3.13 -3.19 -3.38 -4.14 -3.9 -3.66 -2.47 -0.98 -2.28 -1.86 -1.86 -1.94 -0.78 -0.43 -1.51
EBITDA
3.68M -17.43M -21.23M -37.35M -46.42M -56.37M -86.98M -87.89M -75.7M -42.42M 7.45M 10.22M 16.79M 19.61M 17.94M 32.83M 41.19M 19.43M
EBIT
-94.12M -111.26M -94.25M -97M -102.39M -111.62M -140.05M -129.26M -111.54M -71.44M -16.42M -18.83M -11.84M -10.07M -11.66M 12.36M 20.46M -693K
Depreciation & Amortization
97.8M 93.83M 73.02M 59.65M 55.96M 55.26M 53.06M 46.52M 40.99M 34.17M 29.02M 29.04M 28.63M 29.67M 29.6M 31.32M 34.1M 34.39M